Identifikasi Potensi Interaksi Antibiotik pada Resep di Salah Satu Apotek Kota Bandung Bulan Desember 2024

Kirana Fayruz Swarga; Ferry Ferdiansyah Sofian; Ina Siti Sholihah

doi:10.57213/jrikuf.v3i2.624

Authors

Kirana Fayruz Swarga Universitas Padjadjaran
Ferry Ferdiansyah Sofian Universitas Padjadjaran
Ina Siti Sholihah Apotek, Bandung

DOI:

https://doi.org/10.57213/jrikuf.v3i2.624

Keywords:

Antibiotics, Ciprofloxacin, Drug Interaction

Abstract

This study aims to identify and analyze potential antibiotic drug interactions in prescriptions collected from a pharmacy in Bandung during December 2024. A total of 215 prescriptions containing antibiotics were examined, revealing 8 cases of drug interactions, all involving ciprofloxacin. The interactions ranged from minor to major severity levels, with major interactions primarily associated with corticosteroids such as methylprednisolone and dexamethasone. These findings highlight the high interaction potential of ciprofloxacin compared to other antibiotics. The study emphasizes the importance of careful prescribing practices, thorough medication history review, and healthcare provider education to minimize adverse drug reactions. Strengthening drug interaction monitoring systems is crucial to improving patient safety and treatment outcomes.

References

Amilah, H., & Cholisah, E. (2023). Tingkat pengetahuan pengunjung dalam penggunaan antibiotik amoksisilin di Apotek Sehati Jaya. Health Information: Jurnal Penelitian, 15(3), 1–4.

Bailie, G. R., Johnson, C. A., Mason, N. A., & Peter, W. L. S. (2004). Med facts pocket guide of drug interactions. Bone Care International.

Baxter, K. (2010). Stockley’s drug interaction (9th ed.). Pharmaceutical Press.

Bidell, M. R., & Lodise, T. P. (2016). Fluoroquinolone-associated tendinopathy: Does levofloxacin pose the greatest risk? Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 36(6), 679–693. https://doi.org/10.1002/phar.1761

DrugBank. (2025). Drug interaction checker. https://go.drugbank.com/drug-interaction-checker

Drugs.com. (2025). Drug interaction checker. https://www.drugs.com/drug_interactions.html

Fajriansyah, Tahir, H., & Kombong, A. (2016). Kajian drug relation problem (DRPs) kategori interaksi obat, over dosis dan dosis subterapi pada pasien gagal jantung kongestif di RSUP Universitas Hasanudin. Jurnal Ilmiah Farmasi, 5(1). ISSN 2302-2493.

FDA. (2018). FDA reinforces safety information about fluoroquinolone antibiotics. https://www.fda.gov/drugs/drug-safety-and-availability/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side#:~:text=Safety%20Announcement,certain%20mental%20health%20side%20effects

Hermawati, A. H., Surtini, A., Arohman, A. L., & Hariyanto. (2023). Uji antibiotik ciprofloxacin terhadap pertumbuhan Escherichia coli secara in vitro. Jurnal Insan Cendekia, 10(3), 181–188.

Juwono. (2004). Ilmu penyakit dalam (Edisi II). Penerbit Fakultas Kedokteran Universitas Indonesia.

Morales, D. R., Slattery, J., Pacurariu, A., Pinheiro, L., McGettigan, P., & Kurz, X. (2018). Relative and absolute risk of tendon rupture with fluoroquinolone and concomitant fluoroquinolone/corticosteroid therapy: Population-based nested case–control study. Clinical Drug Investigation, 39(2). https://doi.org/10.1007/s40261-018-0729-y

Neli, & Susilawati, Y. (2023). Identifikasi interaksi obat pada resep pasien gangguan pencernaan di Apotek X periode Februari 2023. Farmaka, 21(3).

Reyaan, I. B. M., & Adnyana, I. K. C. (2021). Studi potensi interaksi obat pada resep polifarmasi di dua apotek Kota Bandung. Jurnal Manajemen dan Pelayanan Farmasi, 11(3), 145–152. https://doi.org/10.22146/jmpf.56931

Ruslin, A., et al. (2023). Edukasi penggunaan antibiotik pada masyarakat Desa Leppe Kecamatan Soropia Kabupaten Konawe. Jurnal Pengabdian Farmasi, 1(1), 25–30. https://doi.org/10.33772/mosiraha.v1i1.5

Shariati, A., Arshadi, M., Khosrojerdi, M. A., Abedinzadeh, M., Ganjalishahi, M., Maleki, A., Heidary, M., & Khoshnood, S. (2022). The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2022.1025633